Carvedilol for prevention of chemotherapy-related cardiotoxicity: the CECCY trial (2018)
- Authors:
- Avila, Mônica Samuel - Universidade de São Paulo (USP)
- Ayub-Ferreira, Silvia Moreira - Universidade de São Paulo (USP)
- Wanderley Júnior, Mauro Rogerio de Barros - Universidade de São Paulo (USP)
- Cruz, Fatima das Dores - Universidade de São Paulo (USP)
- Brandão, Sara Michelly Gonçalves - Universidade de São Paulo (USP)
- Rigaud, Vagner Oliveira Carvalho - Universidade de São Paulo (USP)
- Santos, Marília Harumi Higuchi dos
- Hajjar, Ludhmila Abrahão
- Kalil Filho, Roberto
- Hoff, Paulo Marcelo
- Sahade, Marina
- Ferrari, Marcela S M
- Costa, Romulo Leopoldo de Paula
- Mano, Max Senna - Universidade de São Paulo (USP)
- Cruz, Cecília Beatriz Bittencourt Viana - Universidade de São Paulo (USP)
- Abduch, Maria Cristina - Universidade de São Paulo (USP)
- Alves, Marco Stephan Lofrano - Universidade de São Paulo (USP)
- Guimarães, Guilherme Veiga - Universidade de São Paulo (USP)
- Issa, Victor Sarli - Universidade de São Paulo (USP)
- Bittencourt, Márcio Sommer
- Bocchi, Edimar Alcides - Universidade de São Paulo (USP)
- Autor USP: BITTENCOURT, MÁRCIO SOMMER - HU
- Unidade: HU
- DOI: 10.1016/j.jacc.2018.02.049
- Subjects: CARDIOPATIAS; BETA-BLOQUEADORES; HIDROCARBONETOS POLICÍCLICOS; QUIMIOTERAPIA; TOXICOLOGIA
- Language: Inglês
- Imprenta:
- Source:
- Título: Journal of the American College of Cardiology
- ISSN: 0735-1097
- Volume/Número/Paginação/Ano: v. 71, n. 20, p. 2281-2290, may 2018
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
AVILA, Mônica Samuel et al. Carvedilol for prevention of chemotherapy-related cardiotoxicity: the CECCY trial. Journal of the American College of Cardiology, v. 71, n. 20, p. 2281-2290, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.jacc.2018.02.049. Acesso em: 04 mar. 2026. -
APA
Avila, M. S., Ayub-Ferreira, S. M., Wanderley Júnior, M. R. de B., Cruz, F. das D., Brandão, S. M. G., Rigaud, V. O. C., et al. (2018). Carvedilol for prevention of chemotherapy-related cardiotoxicity: the CECCY trial. Journal of the American College of Cardiology, 71( 20), 2281-2290. doi:10.1016/j.jacc.2018.02.049 -
NLM
Avila MS, Ayub-Ferreira SM, Wanderley Júnior MR de B, Cruz F das D, Brandão SMG, Rigaud VOC, Santos MHH dos, Hajjar LA, Kalil Filho R, Hoff PM, Sahade M, Ferrari MSM, Costa RL de P, Mano MS, Cruz CBBV, Abduch MC, Alves MSL, Guimarães GV, Issa VS, Bittencourt MS, Bocchi EA. Carvedilol for prevention of chemotherapy-related cardiotoxicity: the CECCY trial [Internet]. Journal of the American College of Cardiology. 2018 ; 71( 20): 2281-2290.[citado 2026 mar. 04 ] Available from: https://doi.org/10.1016/j.jacc.2018.02.049 -
Vancouver
Avila MS, Ayub-Ferreira SM, Wanderley Júnior MR de B, Cruz F das D, Brandão SMG, Rigaud VOC, Santos MHH dos, Hajjar LA, Kalil Filho R, Hoff PM, Sahade M, Ferrari MSM, Costa RL de P, Mano MS, Cruz CBBV, Abduch MC, Alves MSL, Guimarães GV, Issa VS, Bittencourt MS, Bocchi EA. Carvedilol for prevention of chemotherapy-related cardiotoxicity: the CECCY trial [Internet]. Journal of the American College of Cardiology. 2018 ; 71( 20): 2281-2290.[citado 2026 mar. 04 ] Available from: https://doi.org/10.1016/j.jacc.2018.02.049 - Heart disease and stroke statistics-2019 update: a report From the American Heart Association
- The yield of downstream tests after exercise treadmill testing: a prospective cohort study
- Statin Eligibility in Primary Prevention: From a Risk-Based Strategy to a Personalized Approach Based on the Predicted Benefit
- Coronary calcium score vs. computed tomography angiography as tools to stratify cardiovascular risk
- Implications of coronary artery calcium testing on risk stratification for lipid-lowering therapy according to the 2016 European Society of Cardiology recommendations: The MESA study
- Statin eligibility in primary prevention: from a risk-based strategy to a personalized approach based on the predicted benefit
- Impact of coronary remodeling on fractional flow reserve [letter]
- Percent reduction or target-based strategies to manage blood cholesterol in subjects at intermediate risk: cardiovascular benefit versus diabetes onset risk in real world patients
- Implications of coronary artery calcium testing among statin candidates according to American College of Cardiology/American Heart Association Cholesterol Management Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis)
- Anomalous origin of the coronary artery arising from the opposite sinus: prevalence and outcomes in patients undergoing coronary CTA
Informações sobre o DOI: 10.1016/j.jacc.2018.02.049 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
